Xcube, a leading developer of medical AI solutions, has announced an expansion of its diagnostic software to include multi-organ CT analysis and advanced surgical planning tools. The upgrade aims to improve accuracy in detecting abnormalities across multiple organs and assist surgeons in pre-operative planning, according to company sources.
The new features build on Xcube’s existing AI-powered imaging software, which has been used in hospitals for early disease detection. Analysts note that the expansion reflects growing demand for AI-assisted diagnostics in complex cases involving liver, lung, and kidney conditions. “This could reduce interpretation time by 30-40% for multi-organ scans,” said a healthcare technology analyst familiar with the development.
Medical AI has seen rapid adoption since 2022, with the global market projected to reach $20 billion by 2027. Regulatory approvals for AI diagnostic tools have accelerated in the U.S. and EU, though some clinicians remain cautious about over-reliance on algorithmic assessments.
If successfully implemented, Xcube’s technology may help address radiologist shortages in rural areas. However, experts warn that human oversight remains critical for high-stakes surgical decisions.